Thrombolysis. What is it? A Procedure that removes or destroys clots A Procedure that removes or destroys clots Preformed in a Angio suit Preformed in.

Slides:



Advertisements
Similar presentations
Infection Control: IV Drug Administration
Advertisements

Intravenous Drug Administration
Chapter 3 for 12 Lead Training -Precourse-
Acute Limb Ischaemia John Gan Vascular Surgeon Specialists Without Borders Seminar in Surgery Rwanda, September 2010.
Lecture 4.
Algorithm for the Treatment and Management of Hypoglycaemia in Adults with Diabetes Mellitus in Hospital Hypoglycaemia is a serious condition and should.
EKG at presentation. EKG next day Initial EKG F/u EKG.
Isolated Thrombolysis for DVT DVT Treatment with the Trellis ® Peripheral Infusion System Manufacturer’s Registry Report Gerard J. O’Sullivan MD Mahmood.
1 TLB PowerPoint presented By Takaya L. Brown, BSN, BSN, CMSRN.
When the blood vessels become obstructed, the tissues do not receive the necessary circulation to thrive. Over time, the area may become.
Pulmonary Embolism Jeannette Corona. Title: Alteplase Treatment of Acute Pulmonary Embolism in the Intensive Care Unit Authors: Pamela L. Smithburger,
DR. ahmed Abanamy hospital DOCTOR Nazih Mohammed Alothman Vascular Surgeon.
Fibrinolytic Drugs (Thrombolytic Drugs ) By Prof. Hanan Hagar Dr.Abdul latif Mahesar 1.
SITUATION Hypoglycaemia – blood glucose level
Acute Ischemia Of Lower Limb (AILL)
Angiography and Arteriography SPRING 2009 FINAL
Management of Catheter-Related Complications: Perspective of an Interventional Radiologist Thomas M. Vesely, M.D. Mallinckrodt Institute of Radiology Washington.
Originally Created By: Sheila Elliott MN, RN Revised By: Tina Haayer, RN, BScN.
Pediatric Interventions Cardiac Catheterization and Valvuloplasty.
Acute venous or arterial thrombosis Acute venous or arterial thrombosis Is there clinical concern for an anatomic compressive syndrome or occlusive iliofemoral.
Angiography/ Interventional Basics How do we perform an angiographic procedure? Dr. ABEER FAWZY EL-SOBKY MASTER of RADIOLOGY.
Intra - Arterial Thrombolysis for acute stroke
IVC filters what you need to know Sam Chakraverty Consultant Radiologist Ninewells Hospital Dundee, Scotland.
Treatment of Ischaemic Stroke The American Heart Association American Stroke Association Guidelines Stroke. 2007;38:
THROMBOLYTIC DRUGS (Fibrinolytic drugs) By Prof. Hanan Hagar.
Unit 6 Seminar Chapter 10 HS 200: Diseases of the Human Body Dr. Allan Ayella.
Antiplatelet drugs Dr.V.V.Gouripur. Antiplatelet drug An antiplatelet drug is a member of a class of drugs that decreases platelet aggregation and inhibits.
Fibrinolytic Drugs (Thrombolytic Drugs ) By Prof. Hanan Hagar.
Surgical Grand Rounds 03/10/2013 Thrombolysis never too late
Cardiac Cath and Angiocardiography Adult II FINAL 2/2015.
What Is Lung Cancer? Lung cancer is the uncontrolled growth of abnormal cells in the lung. Normal lung tissue is made up of cells that are programmed.
Epidural Anaesthesia.
THROMBOLYTIC DRUGS (Fibrinolytic drugs) By Prof. Hanan Hagar
Agents Affecting Blood Clotting
Kim, Sun-Yong, M.D. Department of Radiology Ajou University Hospital, Suwon, Korea AGGRESIVE MECHANICAL CLOT DISRUPTION FOR ACUTE ISCHEMIC STROKE WITH.
ClearWay™ RX Therapeutic Perfusion Catheter. ClearWay™ RX In Action Potential Advantages of ClearWay TM: Delivers drug at high concentration to site of.
By: Jasmine Parker, Ariyel Cheatham, and Qyaira Colbert.
Antithrombotic Therapy in Peripheral Artery Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
THROMBOLYTIC DRUGS (Fibrinolytic drugs) By Prof. Hanan Hagar Dr
Cerebral Angiography Radiological study of the blood vessels of the brain to enable physicians to localized and diagnose pathology or anomalies of the.
Radiology Training Course. Timing of Imaging Studies.
Organ Donation & Transplantation EXCI233 Online source: rs/transplantation/overview_of_transplantation.html?qt.
$1 Million $500,000 $250,000 $125,000 $64,000 $32,000 $16,000 $8,000 $4,000 $2,000 $1,000 $500 $300 $200 $100 Welcome.
Material and Methods Patient Population. – From July 2005 through December 2008, 130 patients (130 procedures, 154 limbs, 185 lesions) were treated using.
FMRP 2011 | BEC Popliteal case K. Deloose M. Bosiers.
Open cervical approach for carotid artery stenting
Anticoagulation after peripheral Vascular Intervention
THROMBOLYTICS OR FIBRINOLYTICS.
A novel interventional method for treating femoral pseudoaneurysms
Miscellaneous Diagnostic Tests and Treatments
Fibrinolytic Drugs (Thrombolytic Drugs )
Fundamental Nursing Chapter 35 Intravenous Medications
Cardiac Cath NUR 422.
A patient with multiple paradoxical emboli
Patient conscious, orientated and able to swallow
Correction Journal of Vascular Surgery
Anthony J. Comerota, MD, Steven S. Gale, MD 
Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,
Clinical Relevance of Clot Selectivity
Fundamental Nursing Chapter 35 Intravenous Medications
Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization 
Treatment of limb-threatening ischemia with percutaneous intentional extraluminal recanalization: a preliminary evaluation  Gerald S Treiman, MD, John.
Flow control technique to prevent distal embolization during mechanical thrombectomy  Mathew Wooster, MD, Daniel Kloda, DO, Jacob Robison, MD, Joseph Hart,
ASS.Lec. Suad Turky Ali Lec -10-
Local thrombolysis in the treatment of thrombosed arteries, bypass grafts, and arteriovenous fistulas  Robert A. Graor, M.D., Barbara Risius, M.D., Kevin.
Current status of thrombolytic therapy
Success of thrombolysis as a predictor of outcome in acute thrombosis of popliteal aneurysms  Bettina Marty, MDa, Stephan Wicky, MDb, Hans-Beat Ris, MDc,
ASS.Lec. Suad Turky Ali Lec -10-
Martin E. Harrington, MD, Myron E. Schwartz, MD, Timothy A
Local thrombolysis in the treatment of arterial graft occlusions
Presentation transcript:

Thrombolysis

What is it? A Procedure that removes or destroys clots A Procedure that removes or destroys clots Preformed in a Angio suit Preformed in a Angio suit Many times both a Radiologist and a Vascular surgeon Many times both a Radiologist and a Vascular surgeon Most common reason for during procedure is {peripheral Arterial Occlusive Disease Most common reason for during procedure is {peripheral Arterial Occlusive Disease

Techniques Introduction of catheter into the Femoral Artery Introduction of catheter into the Femoral Artery Catheter Advanced to the clot site Catheter Advanced to the clot site Different Drugs are administered to the site Different Drugs are administered to the site Streptokinase, Urokinase, or rtPA Streptokinase, Urokinase, or rtPA

Techniques Catheter placement in Femoral Artery

Techniques Local Low Dose Thrombolysis Local Low Dose Thrombolysis Discovered by Dotter in 1974 Discovered by Dotter in 1974 Less hazardous treatment Less hazardous treatment More efficient More efficient Pharmaceutical - Streptokinase Pharmaceutical - Streptokinase

Techniques Local Low-Dose Unlike other techniques at the time the dose is reduced to 1/20 the size Unlike other techniques at the time the dose is reduced to 1/20 the size Very popular in treating ilio-femoral Thrombosuses Very popular in treating ilio-femoral Thrombosuses

Techniques Local Low-Dose Advantages Advantages Pure drug right to thrombus Pure drug right to thrombus Protection of lytic agents from antibodies and inhibitors Protection of lytic agents from antibodies and inhibitors Loading dose not necessary Loading dose not necessary Shorter infusion time Shorter infusion time Less costly Less costly

Techniques Local Low-Dose

Techniques Urokinase Infusion This technique is most used for patients with low risk of tissue infarction This technique is most used for patients with low risk of tissue infarction Catheter is placed in the affected artery Catheter is placed in the affected artery Tip is placed 5 to 10mm from clot site Tip is placed 5 to 10mm from clot site Urokinase is infused at a rate of 60 ml/hr Urokinase is infused at a rate of 60 ml/hr Patient is brought back to department every 4 to 8 hours to check Clot Lysis Patient is brought back to department every 4 to 8 hours to check Clot Lysis

Techniques McNamara Infusion The procedure again uses the placement of catheters to the clot site The procedure again uses the placement of catheters to the clot site This procedure is specially used for patients at high risk for Limb or Organ lose This procedure is specially used for patients at high risk for Limb or Organ lose Much like the Low-Dose technique but, infusion rate is quadrupled for first 6 hours Much like the Low-Dose technique but, infusion rate is quadrupled for first 6 hours

Techniques McNamara Infusion Once clot shows signs of dissolving then rate is slowed to that of the Low-Dose technique Once clot shows signs of dissolving then rate is slowed to that of the Low-Dose technique If clot does not show any signs of breaking down the patients will often be sent to surgery to have organ or limb removed If clot does not show any signs of breaking down the patients will often be sent to surgery to have organ or limb removed

Techniques Hess Catheter is advanced to the clot site Catheter is advanced to the clot site Either Streptokinase or Urokinase can be used Either Streptokinase or Urokinase can be used A hand injected method is used A hand injected method is used 1 to 3 ml is given every 5 minutes 1 to 3 ml is given every 5 minutes

Techniques Hess Advantages Advantages Operator is able to view clot breaking down under fluoroscopy, chase clot as it moves Operator is able to view clot breaking down under fluoroscopy, chase clot as it moves Operator has full control of when drug is administered Operator has full control of when drug is administered Shorter procedure Shorter procedure